drugset / Trial / NCT04516603
Influence of Fampridine on Working Memory in Healthy Subjects
Phase 2
Withdrawn
University of Basel
Clinical Trial Unit, University Hospital Basel, Switzerland · collabUniversity Hospital, Basel, Switzerland · collab
RandomizedCrossoverQuadruple-blindBasic science
Summary
Proof-of-concept study on the effects of 10 mg fampridine (oral administration) on working memory in healthy participants. The hypotheses is that fampridine improves working memory performance.
Timeline
- Start
- 2040-01-01
- Primary completion
- 2041-12-31
- Completion
- 2041-12-31
Outcome
Outcome not reported
Stopped: “Changement of study design. Restart spring 2021. See new registration number: NCT04652557 (FamH)”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dalfampridine | Unknown | 10 mg | Oral |
Indications
No indication recorded.